China price cap regulations in the pipeline, but US industry looks at options
This article was originally published in Clinica
Executive Summary
China is planning to regulate medical device pricing, according to new guidelines that will cap the price of medicines at 15% above their purchase price for non-profit health providers, such as hospitals.